219 related articles for article (PubMed ID: 23413262)
1. Novel deletion of lysine 7 expands the clinical, histopathological and genetic spectrum of TPM2-related myopathies.
Davidson AE; Siddiqui FM; Lopez MA; Lunt P; Carlson HA; Moore BE; Love S; Born DE; Roper H; Majumdar A; Jayadev S; Underhill HR; Smith CO; von der Hagen M; Hubner A; Jardine P; Merrison A; Curtis E; Cullup T; Jungbluth H; Cox MO; Winder TL; Abdel Salam H; Li JZ; Moore SA; Dowling JJ
Brain; 2013 Feb; 136(Pt 2):508-21. PubMed ID: 23413262
[TBL] [Abstract][Full Text] [Related]
2. K7del is a common TPM2 gene mutation associated with nemaline myopathy and raised myofibre calcium sensitivity.
Mokbel N; Ilkovski B; Kreissl M; Memo M; Jeffries CM; Marttila M; Lehtokari VL; Lemola E; Grönholm M; Yang N; Menard D; Marcorelles P; Echaniz-Laguna A; Reimann J; Vainzof M; Monnier N; Ravenscroft G; McNamara E; Nowak KJ; Laing NG; Wallgren-Pettersson C; Trewhella J; Marston S; Ottenheijm C; North KN; Clarke NF
Brain; 2013 Feb; 136(Pt 2):494-507. PubMed ID: 23378224
[TBL] [Abstract][Full Text] [Related]
3. Mutation update and genotype-phenotype correlations of novel and previously described mutations in TPM2 and TPM3 causing congenital myopathies.
Marttila M; Lehtokari VL; Marston S; Nyman TA; Barnerias C; Beggs AH; Bertini E; Ceyhan-Birsoy O; Cintas P; Gerard M; Gilbert-Dussardier B; Hogue JS; Longman C; Eymard B; Frydman M; Kang PB; Klinge L; Kolski H; Lochmüller H; Magy L; Manel V; Mayer M; Mercuri E; North KN; Peudenier-Robert S; Pihko H; Probst FJ; Reisin R; Stewart W; Taratuto AL; de Visser M; Wilichowski E; Winer J; Nowak K; Laing NG; Winder TL; Monnier N; Clarke NF; Pelin K; Grönholm M; Wallgren-Pettersson C
Hum Mutat; 2014 Jul; 35(7):779-90. PubMed ID: 24692096
[TBL] [Abstract][Full Text] [Related]
4. A novel TPM2 gene splice-site mutation causes severe congenital myopathy with arthrogryposis and dysmorphic features.
Mroczek M; Kabzińska D; Chrzanowska KH; Pronicki M; Kochański A
J Appl Genet; 2017 May; 58(2):199-203. PubMed ID: 27726070
[TBL] [Abstract][Full Text] [Related]
5. Myopathies associated with β-tropomyosin mutations.
Tajsharghi H; Ohlsson M; Palm L; Oldfors A
Neuromuscul Disord; 2012 Nov; 22(11):923-33. PubMed ID: 22749895
[TBL] [Abstract][Full Text] [Related]
6. A recurrent pathogenic variant in TPM2 reveals further phenotypic and genetic heterogeneity in multiple pterygium syndrome-related disorders.
Vogt J; Al-Saedi A; Willis T; Male A; McKie A; Kiely N; Maher ER
Clin Genet; 2020 Jun; 97(6):908-914. PubMed ID: 32092148
[TBL] [Abstract][Full Text] [Related]
7. Mutations in the beta-tropomyosin (TPM2) gene--a rare cause of nemaline myopathy.
Donner K; Ollikainen M; Ridanpää M; Christen HJ; Goebel HH; de Visser M; Pelin K; Wallgren-Pettersson C
Neuromuscul Disord; 2002 Feb; 12(2):151-8. PubMed ID: 11738357
[TBL] [Abstract][Full Text] [Related]
8. A myopathy-linked tropomyosin mutation severely alters thin filament conformational changes during activation.
Ochala J; Iwamoto H; Larsson L; Yagi N
Proc Natl Acad Sci U S A; 2010 May; 107(21):9807-12. PubMed ID: 20457903
[TBL] [Abstract][Full Text] [Related]
9. Variants in tropomyosins TPM2 and TPM3 causing muscle hypertonia.
Wallgren-Pettersson C; Jokela M; Lehtokari VL; Tyynismaa H; Sainio MT; Ylikallio E; Tynninen O; Pelin K; Auranen M
Neuromuscul Disord; 2024 Feb; 35():29-32. PubMed ID: 38219297
[TBL] [Abstract][Full Text] [Related]
10. Cap disease caused by heterozygous deletion of the beta-tropomyosin gene TPM2.
Lehtokari VL; Ceuterick-de Groote C; de Jonghe P; Marttila M; Laing NG; Pelin K; Wallgren-Pettersson C
Neuromuscul Disord; 2007 Jun; 17(6):433-42. PubMed ID: 17434307
[TBL] [Abstract][Full Text] [Related]
11. Cap disease due to mutation of the beta-tropomyosin gene (TPM2).
Clarke NF; Domazetovska A; Waddell L; Kornberg A; McLean C; North KN
Neuromuscul Disord; 2009 May; 19(5):348-51. PubMed ID: 19345583
[TBL] [Abstract][Full Text] [Related]
12. Whole-Body muscle MRI in a series of patients with congenital myopathy related to TPM2 gene mutations.
Jarraya M; Quijano-Roy S; Monnier N; Béhin A; Avila-Smirnov D; Romero NB; Allamand V; Richard P; Barois A; May A; Estournet B; Mercuri E; Carlier PG; Carlier RY
Neuromuscul Disord; 2012 Oct; 22 Suppl 2():S137-47. PubMed ID: 22980765
[TBL] [Abstract][Full Text] [Related]
13. Homozygous intronic variants in TPM2 cause recessively inherited Escobar variant of multiple pterygium syndrome and congenital myopathy.
Schirwani S; Sarkozy A; Phadke R; Childs AM; Mein R; Ismail A; Smith A; Muntoni F; Hobson E; Pysden K
Neuromuscul Disord; 2021 Apr; 31(4):359-366. PubMed ID: 33558124
[TBL] [Abstract][Full Text] [Related]
14. A pathogenic mechanism associated with myopathies and structural birth defects involves TPM2-directed myogenesis.
McAdow J; Yang S; Ou T; Huang G; Dobbs MB; Gurnett CA; Greenberg MJ; Johnson AN
JCI Insight; 2022 Jun; 7(12):. PubMed ID: 35579956
[TBL] [Abstract][Full Text] [Related]
15. Alteration of tropomyosin function and folding by a nemaline myopathy-causing mutation.
Moraczewska J; Greenfield NJ; Liu Y; Hitchcock-DeGregori SE
Biophys J; 2000 Dec; 79(6):3217-25. PubMed ID: 11106625
[TBL] [Abstract][Full Text] [Related]
16. Absence of beta-tropomyosin is a new cause of Escobar syndrome associated with nemaline myopathy.
Monnier N; Lunardi J; Marty I; Mezin P; Labarre-Vila A; Dieterich K; Jouk PS
Neuromuscul Disord; 2009 Feb; 19(2):118-23. PubMed ID: 19155175
[TBL] [Abstract][Full Text] [Related]
17. Skeletal muscle disease due to mutations in tropomyosin, troponin and cofilin.
Clarke NF
Adv Exp Med Biol; 2008; 642():40-54. PubMed ID: 19181092
[TBL] [Abstract][Full Text] [Related]
18. New morphologic and genetic findings in cap disease associated with beta-tropomyosin (TPM2) mutations.
Ohlsson M; Quijano-Roy S; Darin N; Brochier G; Lacène E; Avila-Smirnow D; Fardeau M; Oldfors A; Tajsharghi H
Neurology; 2008 Dec; 71(23):1896-901. PubMed ID: 19047562
[TBL] [Abstract][Full Text] [Related]
19. Myopathy-causing Q147P TPM2 mutation shifts tropomyosin strands further towards the open position and increases the proportion of strong-binding cross-bridges during the ATPase cycle.
Karpicheva OE; Simonyan AO; Kuleva NV; Redwood CS; Borovikov YS
Biochim Biophys Acta; 2016 Mar; 1864(3):260-267. PubMed ID: 26708479
[TBL] [Abstract][Full Text] [Related]
20. The Primary Causes of Muscle Dysfunction Associated with the Point Mutations in Tpm3.12; Conformational Analysis of Mutant Proteins as a Tool for Classification of Myopathies.
Borovikov YS; Karpicheva OE; Simonyan AO; Avrova SV; Rogozovets EA; Sirenko VV; Redwood CS
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
